Zolpidem extended-release formulations have been discontinued by several manufacturers.
Why Was Zolpidem Extended Release Discontinued?
The discontinuation of zolpidem extended-release products appears to be a business decision by manufacturers. For instance, Teva Pharmaceuticals discontinued its extended-release zolpidem product, leading to a shortage [1]. Similar discontinuations have been noted for other extended-release versions of zolpidem [2].
What Zolpidem Products Are Still Available?
While extended-release versions have faced discontinuations, immediate-release zolpidem tablets remain available from multiple manufacturers [1][2]. This includes the brand-name Ambien and its generic versions.
When Did Extended-Release Zolpidem Become Unavailable?
The timeline for discontinuations varies by manufacturer. Teva's discontinuation of its extended-release zolpidem occurred in early 2023 [1]. Other manufacturers have also ceased production of their extended-release formulations, contributing to product unavailability [2].
What Are the Implications of Zolpidem Extended Release Discontinuation for Patients?
Patients who relied on the extended-release formulation may experience difficulties obtaining their prescribed medication. This could necessitate a switch to immediate-release zolpidem or alternative sleep aids. Consulting with a healthcare provider is recommended to manage this transition and ensure continued effective treatment for insomnia [3].
Are There Alternatives to Zolpidem Extended Release?
Alternatives to zolpidem extended-release include immediate-release zolpidem, which provides a faster onset of action. Other classes of sleep medications, such as benzodiazepines and non-benzodiazepine hypnotics, are also available. Behavioral therapies for insomnia, like Cognitive Behavioral Therapy for Insomnia (CBT-I), are also considered a first-line treatment [3].
What About Other Zolpidem Formulations?
Zolpidem is also available in other forms, including sublingual tablets and oral spray, which offer different administration routes and onset of action profiles [3].
What Are the Risks of Switching Zolpidem Formulations?
Switching from an extended-release to an immediate-release formulation may alter the sleep-onset and sleep-maintenance characteristics of the medication. Patients may experience a quicker onset of sedation and potentially a shorter duration of action. It is crucial for patients to discuss any potential risks and benefits of formulation changes with their doctor [3].
Where Can I Find Information on Drug Product Discontinuations?
Information on drug product discontinuations, including specific details about zolpidem extended-release, can often be found through pharmaceutical news outlets and regulatory agencies. DrugPatentWatch.com tracks patent information and market exclusivity for pharmaceutical products, which can indirectly reflect manufacturing and market decisions [4].
Sources
1. https://www.drugpatentwatch.com/blog/teva-discontinues-zolpidem-er-tablets-causing-shortages/
2. https://www.drugpatentwatch.com/blog/zolpidem-er-discontinued-by-manufacturers-patients-seek-alternatives/
3. https://www.drugs.com/zolpidem.html
4. https://www.drugpatentwatch.com/